Antimicrobial Agents and Chemotherapy · 2009 · 180 citations · 25 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMicrobial GeneticsAntibiotic ResistanceAntibiotic Resistance GeneticsAntibiotic Resistance MechanismsChemotherapy ResistanceDrug Resistance TestingFluoroquinolone AntibioticsFluoroquinolone Resistance MechanismsMolecular Drug ResistanceMolecular Drug Susceptibility TestingMutationPhenotypic Drug Susceptibility TestingTuberculosis Drug Resistance
This study evaluated cross-resistance of Mycobacterium tuberculosis strains to ofloxacin, moxifloxacin, and gatifloxacin and investigated the presence of mutations in gyrA and gyrB. Fluoroquinolone susceptibilities were determined for 41 M. tuberculosis strains by the proportion method on 7H11, and MICs were determined by the resazurin microtiter assay. Forty strains shared the same resistance results for the three fluoroquinolones. However, one strain, with an Asn-533 --> Thr mutation in gyrB, was susceptible to ofloxacin but resistant to moxifloxacin and gatifloxacin.
25
Howard Takiff, L Salazar, Carmen Guerrero et al. · Antimicrobial Agents and Chemotherapy · 1994 · 481 citations · Full text